Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 686

1.

Combined Androgen Blockade in Localized Prostate Cancer Treated With Definitive Radiation Therapy.

Vitzthum LK, Straka C, Sarkar RR, McKay R, Randall JM, Sandhu A, Murphy JD, Rose BS.

J Natl Compr Canc Netw. 2019 Dec;17(12):1497-1504. doi: 10.6004/jnccn.2019.7335.

PMID:
31805534
2.

Narrow Optical Line Widths in Erbium Implanted in TiO2.

Phenicie CM, Stevenson P, Welinski S, Rose BC, Asfaw AT, Cava RJ, Lyon SA, de Leon NP, Thompson JD.

Nano Lett. 2019 Dec 2. doi: 10.1021/acs.nanolett.9b03831. [Epub ahead of print]

PMID:
31765161
3.

Predicting Persistent Opioid Use, Abuse and Toxicity Among Cancer Survivors.

Vitzthum LK, Riviere P, Sheridan P, Nalawade V, Deka R, Furnish T, Mell LK, Rose B, Wallace M, Murphy JD.

J Natl Cancer Inst. 2019 Nov 22. pii: djz200. doi: 10.1093/jnci/djz200. [Epub ahead of print]

PMID:
31754696
4.

A Magic Therapy Program to Alleviate Anxiety in Pediatric Inpatients.

Pravder HD, Leng-Smith A, Brash AI, Elkin DJ, Attard M, Rose B, Messina CR, Chitkara MB.

Hosp Pediatr. 2019 Dec;9(12):942-948. doi: 10.1542/hpeds.2019-0212. Epub 2019 Nov 1.

PMID:
31676585
5.

Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults.

Kumar A, Nalawade V, Riviere P, Sarkar RR, Parsons JK, Murphy JD, Rose BS.

JAMA Netw Open. 2019 Oct 2;2(10):e1913612. doi: 10.1001/jamanetworkopen.2019.13612. No abstract available.

6.

Tobacco smoking and death from prostate cancer in US veterans.

Riviere P, Kumar A, Luterstein E, Vitzthum LK, Nalawade V, Sarkar RR, Bryant AK, Einck JP, Mundt AJ, Murphy JD, Rose BS.

Prostate Cancer Prostatic Dis. 2019 Oct 17. doi: 10.1038/s41391-019-0178-6. [Epub ahead of print]

PMID:
31624316
7.

Benefits of Targeted Use of 5α-Reductase Inhibitors in Patients With Prostate Cancer-Reply.

Sarkar RR, Rose BS.

JAMA Intern Med. 2019 Oct 1;179(10):1442. doi: 10.1001/jamainternmed.2019.3890. No abstract available.

PMID:
31589266
8.

5α-Reductase Inhibitor Use in Patients With Prostate Cancer-Reply.

Sarkar RR, Rose BS.

JAMA Intern Med. 2019 Oct 1;179(10):1440-1441. doi: 10.1001/jamainternmed.2019.3620. No abstract available.

PMID:
31589264
9.

Enhancing Access to Quality Online Training to Strengthen Public Health Preparedness and Response.

Wood SJ, Rogers MH, Frost MC, Revere D, Rose BA, DʼAmbrosio L.

J Public Health Manag Pract. 2019 Nov/Dec;25(6):E1-E9. doi: 10.1097/PHH.0000000000000811.

10.

A Matched Case-Control Analysis of Clinical Outcomes for Patients With Inflammatory Bowel Disease and Rectal Cancer Treated With Pelvic Radiation Therapy.

Mudgway R, Bryant AK, Heide ES, Riviere P, O'Hare C, Rose BS, Murphy JD, Simpson DR.

Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):994-1004. doi: 10.1016/j.ijrobp.2019.08.023. Epub 2019 Aug 25.

PMID:
31461672
11.

Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer.

Sarkar RR, Bryant AK, Parsons JK, Ryan ST, Karim Kader A, Kane CJ, McKay RR, Sandhu A, Murphy JD, Rose BS.

Eur Urol Oncol. 2019 Sep;2(5):584-588. doi: 10.1016/j.euo.2018.09.015. Epub 2018 Oct 19.

PMID:
31411995
12.

Eye tracking in cytotechnology education: "visualizing" students becoming experts.

Mukherjee M, Donnelly A, Rose B, Warren DE, Lyden E, Chantziantoniou N, Dimmitt B, Varley K, Pantanowitz L.

J Am Soc Cytopathol. 2019 Jul 10. pii: S2213-2945(19)30093-6. doi: 10.1016/j.jasc.2019.07.002. [Epub ahead of print]

PMID:
31401035
13.

Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen Level.

Muralidhar V, Nguyen PL, Mahal BA, Yang DD, Mouw KW, Rose BS, Beard CJ, Efstathiou JA, Martin NE, King MT, Orio PF.

J Natl Compr Canc Netw. 2019 Aug 1;17(8):941-948. doi: 10.6004/jnccn.2018.7283.

PMID:
31390585
14.

Female genital mutilation in the UK: considerations for best nursing practice.

Rose B.

Br J Nurs. 2019 Jun 27;28(12):788-791. doi: 10.12968/bjon.2019.28.12.788.

PMID:
31242117
15.

Genetically Modified Babies and a First Application of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR-Cas9).

Rose BI, Brown S.

Obstet Gynecol. 2019 Jul;134(1):157-162. doi: 10.1097/AOG.0000000000003327.

PMID:
31188312
16.

Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.

Sarkar RR, Parsons JK, Bryant AK, Ryan ST, Kader AK, McKay RR, D'Amico AV, Nguyen PL, Hulley BJ, Einck JP, Mundt AJ, Kane CJ, Murphy JD, Rose BS.

JAMA Intern Med. 2019 Jun 1;179(6):812-819. doi: 10.1001/jamainternmed.2019.0280.

PMID:
31058923
17.

Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy.

Deka R, Simpson DR, Panizzon MS, Hauger RL, Riviere P, Nalawade V, McKay R, Murphy JD, Rose BS.

Prostate Cancer Prostatic Dis. 2019 Dec;22(4):600-608. doi: 10.1038/s41391-019-0150-5. Epub 2019 Apr 15.

PMID:
30988408
18.

Increased HIV diagnoses in West Virginia counties highly vulnerable to rapid HIV dissemination through injection drug use: a cautionary tale.

Bradley H, Hogan V, Agnew-Brune C, Armstrong J, Broussard D, Buchacz K, Burton K, Cope S, Dawson E, De La Garza G, Gerard A, Granado M, Gupta R, Haddy L, Hoffman W, Johnson SD, Kirk N, Lee C, Lyss S, Mark-Carew M, Quilter L, Reynolds P, Rose B, Thompson A, Varella L, Weidle P, White B, Wills D, Young SA, Hoots BE.

Ann Epidemiol. 2019 Jun;34:12-17. doi: 10.1016/j.annepidem.2019.02.012. Epub 2019 Mar 6.

PMID:
30967302
19.

In Reply to Hurmuz and Ozyigit.

Bryant AK, Rose BS.

Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):225. doi: 10.1016/j.ijrobp.2019.01.084. No abstract available.

PMID:
30967234
20.

Claims-Based Approach to Predict Cause-Specific Survival in Men With Prostate Cancer.

Riviere P, Tokeshi C, Hou J, Nalawade V, Sarkar R, Paravati AJ, Schiaffino M, Rose B, Xu R, Murphy JD.

JCO Clin Cancer Inform. 2019 Mar;3:1-7. doi: 10.1200/CCI.18.00111.

21.

Evolution of the Radiation Therapist Role in a Multidisciplinary Palliative Radiation Oncology Clinic.

LeGuerrier B, Huang F, Spence W, Rose B, Middleton J, Palen M, Thvone K, Ravji S, Danielson B, Severin D, Chu KP, Fairchild A.

J Med Imaging Radiat Sci. 2019 Mar;50(1):17-23.e1. doi: 10.1016/j.jmir.2018.07.005. Epub 2018 Sep 7.

PMID:
30777240
22.

Collision cross section compendium to annotate and predict multi-omic compound identities.

Picache JA, Rose BS, Balinski A, Leaptrot KL, Sherrod SD, May JC, McLean JA.

Chem Sci. 2018 Nov 27;10(4):983-993. doi: 10.1039/c8sc04396e. eCollection 2019 Jan 28.

23.

Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy.

Deka R, Rose BS, Bryant AK, Sarkar RR, Nalawade V, McKay R, Murphy JD, Simpson DR.

Cancer. 2019 Apr 1;125(7):1070-1080. doi: 10.1002/cncr.31982. Epub 2019 Feb 12.

PMID:
30748008
24.

Postoperative radiation and hormonal therapy for men with node-positive prostate cancer: a new standard?

Rose BS.

BJU Int. 2019 Feb;123(2):199-200. doi: 10.1111/bju.14501. No abstract available.

PMID:
30656836
25.

Prediction of higher-selectivity catalysts by computer-driven workflow and machine learning.

Zahrt AF, Henle JJ, Rose BT, Wang Y, Darrow WT, Denmark SE.

Science. 2019 Jan 18;363(6424). pii: eaau5631. doi: 10.1126/science.aau5631.

26.

Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer.

Bryant AK, McKay RR, Kader AK, Parsons JK, Einck JP, Kane CJ, Mundt AJ, Murphy JD, Rose BS.

Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1068-1076. doi: 10.1016/j.ijrobp.2018.12.001. Epub 2018 Dec 11.

PMID:
30543857
27.

Initiating Advance Care Planning in Primary Care: A Model for Success.

Rose BL, Leung S, Gustin J, Childers J.

J Palliat Med. 2019 Apr;22(4):427-431. doi: 10.1089/jpm.2018.0380. Epub 2018 Nov 27.

PMID:
30481086
28.

Detecting a Survival Benefit to Dose Escalation.

Zakeri K, Rose BS, Mell LK.

JAMA Oncol. 2019 Jan 1;5(1):109-110. doi: 10.1001/jamaoncol.2018.5055. No abstract available.

29.

Untargeted Molecular Discovery in Primary Metabolism: Collision Cross Section as a Molecular Descriptor in Ion Mobility-Mass Spectrometry.

Nichols CM, Dodds JN, Rose BS, Picache JA, Morris CB, Codreanu SG, May JC, Sherrod SD, McLean JA.

Anal Chem. 2018 Dec 18;90(24):14484-14492. doi: 10.1021/acs.analchem.8b04322. Epub 2018 Nov 30.

30.

Differentiation of Hemorrhage from Iodine Using Spectral Detector CT: A Phantom Study.

Van Hedent S, Hokamp NG, Laukamp KR, Buls N, Kessner R, Rose B, Ros P, Jordan D.

AJNR Am J Neuroradiol. 2018 Dec;39(12):2205-2210. doi: 10.3174/ajnr.A5872. Epub 2018 Nov 8.

31.

Multivariable analysis to determine risk factors associated with early pregnancy loss in thoroughbred broodmares.

de Mestre AM, Rose BV, Chang YM, Wathes DC, Verheyen KLP.

Theriogenology. 2019 Jan 15;124:18-23. doi: 10.1016/j.theriogenology.2018.10.008. Epub 2018 Oct 9.

PMID:
30326374
32.

Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy.

Deka R, Simpson DR, Bryant AK, Nalawade V, McKay R, Murphy JD, Rose BS.

JAMA Oncol. 2018 Nov 1;4(11):1616-1617. doi: 10.1001/jamaoncol.2018.4423. No abstract available.

33.

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.

Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Desai A, Sulai N, Ritterhouse L, Røe OD, Turaga KK, Huo D, Segal J, Kadri S, Li Z, Kindler HL, Churpek JE.

J Clin Oncol. 2018 Oct 1;36(28):2863-2871. doi: 10.1200/JCO.2018.78.5204. Epub 2018 Aug 16.

34.

Psychiatric symptom severity, criminal risk, and suicidal ideation and attempts among not guilty by reason of insanity state hospital inpatients.

Mitchell SM, Brown SL, Bolaños AD, Rose B, Delgado D, Morgan RD, Velasquez S, Cukrowicz KC.

Psychol Serv. 2018 Aug;15(3):340-348. doi: 10.1037/ser0000209.

PMID:
30080093
35.

A Simple Colorimetric System for Detecting Target Antigens by a Three-Stage Signal Transformation-Amplification Strategy.

Liao AM, Pan W, Benson JC, Wong AD, Rose BJ, Caltagirone GT.

Biochemistry. 2018 Aug 28;57(34):5117-5126. doi: 10.1021/acs.biochem.8b00523. Epub 2018 Aug 13.

PMID:
30064210
36.

In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma.

Pyuen AA, Meuten T, Rose BJ, Thamm DH.

PLoS One. 2018 Jul 16;13(7):e0200634. doi: 10.1371/journal.pone.0200634. eCollection 2018.

37.

Observation of an environmentally insensitive solid-state spin defect in diamond.

Rose BC, Huang D, Zhang ZH, Stevenson P, Tyryshkin AM, Sangtawesin S, Srinivasan S, Loudin L, Markham ML, Edmonds AM, Twitchen DJ, Lyon SA, de Leon NP.

Science. 2018 Jul 6;361(6397):60-63. doi: 10.1126/science.aao0290.

PMID:
29976820
38.

Osteoarthritis-Like Changes in Bardet-Biedl Syndrome Mutant Ciliopathy Mice (Bbs1M390R/M390R): Evidence for a Role of Primary Cilia in Cartilage Homeostasis and Regulation of Inflammation.

Sheffield ID, McGee MA, Glenn SJ, Baek DY, Coleman JM, Dorius BK, Williams C, Rose BJ, Sanchez AE, Goodman MA, Daines JM, Eggett DL, Sheffield VC, Suli A, Kooyman DL.

Front Physiol. 2018 Jun 19;9:708. doi: 10.3389/fphys.2018.00708. eCollection 2018.

39.

Dynamic contrast-enhanced CT for the assessment of tumour response in malignant pleural mesothelioma: a pilot study.

Gudmundsson E, Labby Z, Straus CM, Sensakovic WF, Li F, Rose B, Cunliffe A, Kindler HL, Armato SG 3rd.

Eur Radiol. 2019 Feb;29(2):682-688. doi: 10.1007/s00330-018-5533-9. Epub 2018 Jul 2.

PMID:
29967955
40.

Human papillomavirus 16 E6 modulates the expression of miR-496 in oropharyngeal cancer.

Mason D, Zhang X, Marques TM, Rose B, Khoury S, Hill M, Deutsch F, Lyons JG, Gama-Carvalho M, Tran N.

Virology. 2018 Aug;521:149-157. doi: 10.1016/j.virol.2018.05.022. Epub 2018 Jun 20.

41.

Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer.

Bryant AK, Kader AK, McKay RR, Einck JP, Mell LK, Mundt AJ, Kane CJ, Efstathiou JA, Murphy JD, Rose BS.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1188-1193. doi: 10.1016/j.ijrobp.2018.04.023. Epub 2018 Apr 17.

PMID:
29891203
42.

"Will she live a long happy life?" Parents' concerns for their children with Fontan circulation.

du Plessis K, Peters R, King I, Robertson K, Mackley J, Maree R, Stanley T, Pickford L, Rose B, Orchard M, Stewart H, d'Udekem Y.

Int J Cardiol Heart Vasc. 2018 Mar 9;18:65-70. doi: 10.1016/j.ijcha.2018.02.008. eCollection 2018 Mar.

43.

Peri-anal surface dose in anal canal VMAT radiotherapy.

Joseph K, Rose B, Warkentin H, Yun J, Ghosh S, Tankel K.

J Med Imaging Radiat Oncol. 2018 Oct;62(5):734-738. doi: 10.1111/1754-9485.12748. Epub 2018 May 23.

PMID:
29797501
44.

Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy.

Bryant AK, D'Amico AV, Nguyen PL, Einck JP, Kane CJ, McKay RR, Simpson DR, Mundt AJ, Murphy JD, Rose BS.

Cancer. 2018 Jul 15;124(14):2939-2947. doi: 10.1002/cncr.31400. Epub 2018 May 4.

45.

In vitro antineoplastic effects of auranofin in canine lymphoma cells.

Zhang H, Rose BJ, Pyuen AA, Thamm DH.

BMC Cancer. 2018 May 3;18(1):522. doi: 10.1186/s12885-018-4450-2.

46.

Who benefits most from early salvage radiation therapy after prostatectomy?

Nath SK, Rose BS, Pugh TJ.

Transl Androl Urol. 2018 Mar;7(Suppl 1):S124-S127. doi: 10.21037/tau.2017.11.23. No abstract available.

47.

"How long will I continue to be normal?" Adults with a Fontan circulation's greatest concerns.

du Plessis K, Peters R, King I, Robertson K, Mackley J, Maree R, Stanley T, Pickford L, Rose B, Orchard M, Stewart H, d'Udekem Y.

Int J Cardiol. 2018 Jun 1;260:54-59. doi: 10.1016/j.ijcard.2018.01.098.

PMID:
29622455
48.

Salvage image guided radiation therapy to the prostate after cryotherapy failure.

Hopper AB, Sandhu APS, Parsons JK, Rose B, Einck JP.

Adv Radiat Oncol. 2017 Sep 27;3(1):52-56. doi: 10.1016/j.adro.2017.09.001. eCollection 2018 Jan-Mar.

49.

Notes from the Field: HIV Infection Investigation in a Rural Area - West Virginia, 2017.

Evans ME, Labuda SM, Hogan V, Agnew-Brune C, Armstrong J, Periasamy Karuppiah AB, Blankinship D, Buchacz K, Burton K, Cibrik S, Hoffman W, Kirk N, Lee C, McGraw D, Bañez Ocfemia MC, Panneer N, Reynolds P, Rose B, Salmon M, Scott M, Thompson A, Wills D, Young SA, Gupta R, Haddy L, Weidle PJ, Mark-Carew M.

MMWR Morb Mortal Wkly Rep. 2018 Mar 2;67(8):257-258. doi: 10.15585/mmwr.mm6708a6. No abstract available.

50.

Descriptive study of current therapeutic practices, clinical reproductive findings and incidence of pregnancy loss in intensively managed thoroughbred mares.

Rose BV, Firth M, Morris B, Roach JM, Wathes DC, Verheyen KLP, de Mestre AM.

Anim Reprod Sci. 2018 Jan;188:74-84. doi: 10.1016/j.anireprosci.2017.11.011. Epub 2017 Nov 10.

PMID:
29146097

Supplemental Content

Support Center